國防醫學院 生物及解剖學科 徐佳福 助理教授 Room 5363; TEL: 18717 Cell Differentiation • A complex multistep process of cell specialization that begins with the installation of a genetic programme, named determination, specific for a cell lineage. • Development of the differentiation programme includes the cell-type specific silencing of some genes and the expression of other genes, that regulate the biological functions associated with the cellular type and that distinguish the specialized cells. January 8, 2007 Jia-Fwu Shyu 2 Cell Differentiation • Terminal differentiation is the end stage of this process where the cells irreversibly lose their proliferative capacity and which represents a form of negative control of growing. • Regulating molecules interact to produce the correct balance between cellular multiplication and differentiation during embryogenesis and the normal behavior of an adult.
January 8, 2007 Jia-Fwu Shyu 3
Cell Differentiation • Cancer is a process in which changes in regulating circuits are produced, such as – proliferation control, the balance between cellular survival and programmed cell death (apoptosis), – the communication with neighbouring cells and with the extracellular matrix, – angionenesis, and finally, – the migration of tumoural cell, the invasion and metastasic dissemination.
embryonic stem cells in vitro. Nanog maintains self-renewal of mouse embryonic stem cells and represses primitive endoderm fate. Forced expression of Gata6 (in red) induces differentiation to primitive endoderm.
(c) Developmental potentials of human
embryonic stem cells in vitro. Treatment with BMP4 (in red) promotes differentiation to trophectoderm. Nanog maintains self renewal of human embryonic stem cells and represses extra-embryonic fate (trophectoderm and primitive endoderm). Upon overexpression (in red), Nanog promotes differentiation to primitive ectoderm.
January 8, 2007 Jia-Fwu Shyu 6
Specification of primary germ layers and their derivatives
January 8, 2007 Jia-Fwu Shyu 7
Ways of stem cell speciation and differentiation. Solid arrows indicate experimentally proven and Dashed arrows hypothesized ways of cell speciation and/or differentiation
January 8, 2007 Jia-Fwu Shyu 8
Schematic representation of stem cell Differentiation pathways
(A) and (B) depict classical linear
Differentiation pathways from a multipotent stem cell to differentiated tissue progeny.
(C) Depicts the process of de-differentiation
when a presumably terminally differentiated cell can revert to a less-differentiated cell type and then give rise to new mature progeny.
(D) Depicts the process of trans-
differentiation, when a presumably terminally differentiated cell can give rise to other related and, in some instances, unrelated mature cell types
January 8, 2007 Jia-Fwu Shyu 9
Restoring stemness
The hypothesis envisions taking cells from a patient in
need of tissue replacement, exposing them in vitro to factors that reprogram them to a state of multipotency, and subjecting the reprogramed cells to differentiation protocols designed to generate specialized cells. This protocol, if successful, could provide autologous transplants for the patient.
January 8, 2007 Jia-Fwu Shyu 10
Cell Differentiation
Bone
January 8, 2007 Jia-Fwu Shyu 11
Transcriptional control of osteoblastic, chondrocytic, adipocytic and myocytic differentiation
January 8, 2007 Jia-Fwu Shyu 12
Differentiation factors in chondrocytic and osteoblastic differentiation
1. Sox9, together with Sox5 and
Sox6, regulates differentiation of chondrocytes. 2. Runx2 and Osterix control osteoblastic differentiation. 3. Maturation of chondrocytes to hypertrophy is controlled positively by Runx2 and negatively by Sox9. As Runx2 has a role in both chondrocytic and osteoblastic differentiation. 4. Osterix is likely the factor that provides specificity in osteoblastic differentiation.
January 8, 2007 Jia-Fwu Shyu 13
Bipotential adipo-osteoprogenitor cells • Osteoblasts, differentiated to the point of already expressing OCN, are able to undergo rapid differentiation events that lead to essentially 100% of the formerly osteoblastic cells expressing adipogenesis when they are transfected with the nuclear receptor family member peroxisome proliferator-activated receptor γ2 or PPARγ2 • Although osteocalcin (OCN) is a very late marker of osteoblast maturation, data are consistent with osteoblastic cells being able to transfifferentiate into an adipogenic phenoty, an outcome of significant clinical interest in osteoporosis and aging or immobilized skeleton. January 8, 2007 Jia-Fwu Shyu 14 Control of Osteoblast Development • Cbfa1/Runx2: – A member of the runt homology domain transcription factor family, play a crucial role in osteoblast development. – Regulate OCN. – Haploinsufficiency in mice and humans leads to the cleidocranial dysplasia phenotype. – The earliest of osteoblast differentiation markers currently known. – Up regulated in cultures treated with bone morphogenetic proteins (BMP). – Not a master gene, in contrast to MyoD and PPARg2. – Necessary but not sufficient to support differentiation to the mature osteoblast phenotype
January 8, 2007 Jia-Fwu Shyu 15
PPARγ2 • CCAAT/enhancer-binding (C/EBP) protein family, play a key role in adipocyte differentiation. • Is able to transdifferentiate osteoblastic cells to adipocytes, may do so via its ability to downregulate Cbfa1
January 8, 2007 Jia-Fwu Shyu 16
Sox9 • essential for chondrocyte differentiation, expression of various chondrocyte genes, and cartilage formation
January 8, 2007 Jia-Fwu Shyu 17
Indian hedgehog (Ihh) • regulates chondrocyte differentiation • not normally expressed in intramembranous bones • osteoblast differentiation occurs normaly in these bones in Ihh -/- animals • may be regulator of Cbfa1 and osteoblast development, but in a skeletal site-specific manner January 8, 2007 Jia-Fwu Shyu 18 January 8, 2007 Jia-Fwu Shyu 19 January 8, 2007 Jia-Fwu Shyu 20 Osteoprogenitor Cells and Regulation of Osteoblast Differentiation and Activity • Osteoprogenitor Cells – Cell-specific macromolecules: type I collagen, OCN, OPN, BSP. Transcription factors: Cbfa1, AP-1 family members, Msx-2, Dlx-5. – Estimates by limiting dilution have indicated that these osteoprogenitor cells are relatively rare in cell populations digested from fetal rat calvaria (i.e., < 1%) and rat and mouse bone marrow stroma (i.e., 0.5-1 x 10-5 of the nucleated cells of unfractionated marrow or < 1% of the stromal layer) under standard isolation and culture conditions. – Plasticity between mature cell phenotypes normally considered indicative of terminal differentiation can contribute to osteoblast pools, at least in vitro January 8, 2007 Jia-Fwu Shyu 21 Differentiation of Osteoprogenitor Cells to Osteoblasts • Bone nodule formation can be subdivided into three stages: (i) proliferation, (ii) extracellular matrix development and maturation, and (iii) mineralization. • ALP increases and then decreases when mineralization is well progressed; • OPN peaks twice during proliferation and then again later but prior to certain other matrix proteins, including BSP and OCN; • BSP is expressed transiently very early and is then upregulated again in differentiated osteoblasts forming bone; • OCN appears approximately concomitantly with mineralization
January 8, 2007 Jia-Fwu Shyu 22
Differentiation of Osteoprogenitor Cells to Osteoblasts • All these osteoblast-associated marker are upregulated prior to the cessation of proliferation in osteoblast precursors except OCN, which is upregulated only in postproliferative osteoblasts • Differentiation is well progressed before osteoblast precursors leave the proliferative cycle • 12 markers, seven transitional stages • There is heterogeneity among osteoblast developmental pathways and/or the resulting osteoblasts
January 8, 2007 Jia-Fwu Shyu 23
Differentiation of Osteoprogenitor Cells to Osteoblasts • Only two markers of nine sampled, ALP and PTH1R, appeared to be “global” or ”ubiquitous” markers expressed by all osteoblasts in vivo • All other markers analyzed were expressed differentially at both mRNA and protein levels in only subsets of osteoblasts, depending on the maturational state of the bone, the age of the osteoblast, and on the environment • Not all mature osteoblasts develop via the same regulatory mechanisms nor are they identical molecularly or functionally. The makeup of different parts of bones may be significantly different
January 8, 2007 Jia-Fwu Shyu 24
Transcription Factor, Hormone, Cytokine, and Growth Factor Regulation of
CFU-F and Osteoprogenitor Cell Proliferation and Differentiation
• Regulaiton by Transcirption Facotrs
– At least three and perhaps more Cbfa1 isoforms that have been described. – Cbfa1 regulates OCN expression and osteoblast differentiation. – Cbfa1 is regulated by BMPs, but not directly. Cbfa1 regulates itself directly via binding on its own promoter
January 8, 2007 Jia-Fwu Shyu 25
January 8, 2007 Jia-Fwu Shyu 26 January 8, 2007 Jia-Fwu Shyu 27 January 8, 2007 Jia-Fwu Shyu 28 January 8, 2007 Jia-Fwu Shyu 29 Endochondral bone formation
a, Mesenchymal cells condense.
b, Cells of condensations become chondrocytes (c).
c, Chondrocytes at the centre of condensation stop
proliferating and become hypertrophic (h).
d, Perichondrial cells adjacent to hypertrophic
chondrocytes become osteoblasts, forming bone collar (bc). Hypertrophic chondrocytes direct the formation of mineralized matrix, attract blood vessels, and undergo apoptosis.
e, Osteoblasts of primary spongiosa accompany
vascular invasion, forming the primary spongiosa (ps).
f, Chondrocytes continue to proliferate, lengthening the
bone. Osteoblasts of primary spongiosa are precursors of eventual trabecular bone; osteoblasts of bone collar become cortical bone.
g, At the end of the bone, the secondary
ossification centre (soc) forms through cycles of chondrocyte hypertrophy, vascular invasion and osteoblast activity. The growth plate below the secondary centre of ossification forms orderly columns of proliferating chondrocytes (col). Haematopoietic marrow (hm) expands in marrow space along with stromal cells.
January 8, 2007 Jia-Fwu Shyu 30
Indian hedgehog (Ihh)/parathyroid hormone-related protein (PTHrP) negative-feedback loop 1. PTHrP is secreted from perichondrial cells and chondrocytes at the ends of long bones.
2. PTHrP acts on receptors on
proliferating chondrocytes to keep the chondrocytes proliferating and, thereby, to delay the production of Ihh. When the source of PTHrP production is sufficiently distant, then Ihh is produced. The Ihh acts on its receptor on chondrocytes to increase the rate of Proliferation.
3. through a poorly understood
mechanism, stimulates the production of PTHrP at the ends of bones.
4. Ihh also acts on perichondrial cells to
convert these cells into osteoblasts of the bone collar.
January 8, 2007 Jia-Fwu Shyu 31
Osteoclastogenesis
January 8, 2007 Jia-Fwu Shyu 32
Hormonal control of bone resorption
a, pro-resorptive and calcitropic factors
b, anabolic and anti-osteoclastic factors
1) RANKL expression is induced in osteoblasts, activated T cells, synovial fibroblasts and bone marrow stromal cells, and subsequently binds to its specific membrane-bound receptor RANK, thereby triggering a network of TRAF mediated kinase cascades that promote osteoclast differentiation, activation and survival. 2) Conversely, OPG expression is induced by factors that block bone catabolism and promote anabolic effects. OPG binds and neutralizes RANKL, leading to a block In osteoclastogenesis and decreased survival of pre-existing osteoclasts. January 8, 2007 Jia-Fwu Shyu 33 January 8, 2007 Jia-Fwu Shyu 34 January 8, 2007 Jia-Fwu Shyu 35 Leptin signalling pathways
January 8, 2007 Jia-Fwu Shyu 36
Cell Differentiation
Kidney
January 8, 2007 Jia-Fwu Shyu 37
The Kidneys • Intermediate mesoderm (中間中胚層) • Nephrogenic cord (腎索) • 原腎(Pronephros): 發展不完全且不具功能,相當於魚類 的腎臟,在胚胎時期第四週出現,然後不久便退化,但大 部分的原腎管仍然存在,且成為中腎的一部分。 • 中腎(Mesonephros): 發展完全,但只具短暫功能,相當 於兩棲類的腎臟,在胚胎時期第四週末出現。過渡時期腎 臟(Interim kidney):具有腎絲球和中腎小管[mesonephric tubules,形成睪丸的輸精管(efferent ductules of the testes)],再第一個三月期末退化。中腎管(Mesonephric duct):在男性形成性腺管,而女性的輸卵管 (paramesonephric or Mullerian duct)則與腎臟的胚胎發育 無關。
January 8, 2007 Jia-Fwu Shyu 42 January 8, 2007 Jia-Fwu Shyu 43 January 8, 2007 Jia-Fwu Shyu 44 Stages of renal branching morphogenesis and nephron formation
Ureteric bud outgrowth
January 8, 2007 Jia-Fwu Shyu 45
Stages of renal branching morphogenesis and nephron formation
Ureteric bud branching and nephron induction
Ureteric bud branching and nephron formation
Nephron arcade formation
Induction of metanephric mesenchyme by
the branched ureteric bud
January 8, 2007 Jia-Fwu Shyu 46
Stages of renal branching morphogenesis and nephron formation
January 8, 2007 Jia-Fwu Shyu 47
A model for cell lineage during ureteric bud (UB) branching, based on the behavior of wild-type green fluorescent protein (GFP)+cells and Ret-/- cells in chimeric kidneys.
(A) A UB branch contains trunk (green) and tip (blue)
domains. (B), The trunk first elongates without acquiring tips cells, while the tip grows, stimulated by GDNF/Ret signaling, to form the ampulla. (C) As branching ensues (C and D), the ampulla and the adjacent trunk epithelium are remodeled by hypothetical forces (arrows in C), causing the trunk epithelium to form the proximal side of two new trunks (asterisks in E), while tip cells form the two new tips and the distal epithelium of the new trunks (black bracket). (F), Summary of lineage relationships between tip and trunk cells; tip cells generate both tip and trunk cells, while trunk cells generate only more trunk cells during terminal branching (but presumably can form tip cells during lateral branching).
January 8, 2007 Jia-Fwu Shyu Shakya et al. (2005) 48
Cell Differentiation
Pancreas
January 8, 2007 Jia-Fwu Shyu 49
Schematic diagram of pancreatic development in the mouse
January 8, 2007 Jia-Fwu Shyu 50
A simplified hierarchy of transcription factor expression in the developing pancreas